High vs. Standard Dose Rifampicin for Effusive Tuberculous Pericarditis
Clinical trial NCT04521803 · RECRUITING
Trial details
- NCT number
- NCT04521803
- Sponsor
- University of Cape Town
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-10
- Primary completion
- 2025-09-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.